|
1
|
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis.
|
J Clin Invest
|
2012
|
3.46
|
|
2
|
Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
|
Hepatology
|
2009
|
3.42
|
|
3
|
Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis.
|
Hepatology
|
2003
|
1.92
|
|
4
|
Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
|
J Hepatol
|
2005
|
1.70
|
|
5
|
Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis.
|
Hepatology
|
2002
|
1.64
|
|
6
|
Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment.
|
Am J Gastroenterol
|
2004
|
1.63
|
|
7
|
Characteristics of autoimmune hepatitis in Taiwan: the 11 years' experiences of a medical center.
|
Zhonghua Yi Xue Za Zhi (Taipei)
|
2002
|
1.45
|
|
8
|
HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
|
Oncogene
|
2002
|
1.43
|
|
9
|
Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes.
|
Ann Neurol
|
2010
|
1.42
|
|
10
|
Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan.
|
Int J Cancer
|
2006
|
1.40
|
|
11
|
A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.
|
World J Surg
|
2011
|
1.29
|
|
12
|
Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients.
|
Gastroenterology
|
2006
|
1.22
|
|
13
|
Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas.
|
Clin Gastroenterol Hepatol
|
2010
|
1.12
|
|
14
|
Practical difficulties in the management of hepatitis B in the Asia-Pacific region.
|
J Gastroenterol Hepatol
|
2004
|
1.09
|
|
15
|
Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
|
World J Gastroenterol
|
2004
|
1.08
|
|
16
|
Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
|
Liver Int
|
2005
|
1.06
|
|
17
|
Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test.
|
Am J Gastroenterol
|
2002
|
1.05
|
|
18
|
The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy.
|
PLoS One
|
2013
|
1.05
|
|
19
|
Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection?
|
Surgery
|
2012
|
1.04
|
|
20
|
Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study.
|
Am J Gastroenterol
|
2003
|
1.04
|
|
21
|
Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
|
Liver Transpl
|
2006
|
1.02
|
|
22
|
Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
|
Hepatogastroenterology
|
2002
|
1.01
|
|
23
|
Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma.
|
Am J Gastroenterol
|
2003
|
1.00
|
|
24
|
The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey.
|
Am J Gastroenterol
|
2007
|
1.00
|
|
25
|
The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis.
|
Arch Surg
|
2011
|
0.99
|
|
26
|
Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
|
J Clin Gastroenterol
|
2012
|
0.98
|
|
27
|
Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications.
|
Hepatology
|
2002
|
0.98
|
|
28
|
Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
|
J Gastroenterol Hepatol
|
2005
|
0.96
|
|
29
|
Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma.
|
Hepatol Int
|
2010
|
0.96
|
|
30
|
Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study.
|
Liver Int
|
2004
|
0.96
|
|
31
|
Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus.
|
J Gen Virol
|
2004
|
0.95
|
|
32
|
Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index.
|
Eur J Gastroenterol Hepatol
|
2011
|
0.90
|
|
33
|
Risk of oral antifungal agent-induced liver injury in Taiwanese.
|
Br J Clin Pharmacol
|
2014
|
0.89
|
|
34
|
Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection.
|
Eur J Gastroenterol Hepatol
|
2003
|
0.89
|
|
35
|
Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up.
|
PLoS One
|
2013
|
0.88
|
|
36
|
Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
|
J Med Virol
|
2003
|
0.88
|
|
37
|
Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives.
|
J Chin Med Assoc
|
2005
|
0.88
|
|
38
|
Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus.
|
J Virol
|
2007
|
0.87
|
|
39
|
Risk of hepato-biliary cancer after cholecystectomy: a nationwide cohort study.
|
J Gastrointest Surg
|
2012
|
0.86
|
|
40
|
The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.
|
Cancer
|
2006
|
0.86
|
|
41
|
Systemic amyloidosis manifesting as a rare cause of hepatic failure.
|
J Chin Med Assoc
|
2010
|
0.86
|
|
42
|
Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatments.
|
Int J Cancer
|
2013
|
0.86
|
|
43
|
Seroprevalence of hepatitis E virus infection among institutionalized psychiatric patients in Taiwan.
|
J Clin Virol
|
2006
|
0.86
|
|
44
|
Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy.
|
Am J Gastroenterol
|
2006
|
0.85
|
|
45
|
Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias?
|
Scand J Gastroenterol
|
2007
|
0.85
|
|
46
|
Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy.
|
Scand J Gastroenterol
|
2002
|
0.85
|
|
47
|
Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years.
|
Liver Int
|
2008
|
0.85
|
|
48
|
Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area.
|
J Med Virol
|
2014
|
0.84
|
|
49
|
Prognostic significance of computed tomography scan-derived splenic volume in hepatocellular carcinoma treated with radiofrequency ablation.
|
J Clin Gastroenterol
|
2012
|
0.84
|
|
50
|
Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B.
|
Clin Nutr
|
2011
|
0.84
|
|
51
|
Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
|
Liver Int
|
2006
|
0.84
|
|
52
|
Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations.
|
J Med Virol
|
2004
|
0.84
|
|
53
|
Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications.
|
Clin Transplant
|
2006
|
0.84
|
|
54
|
Predictive value of aspartate aminotransferase to alanine aminotransferase ratio for hepatic fibrosis and clinical adverse outcomes in patients with primary biliary cirrhosis.
|
J Clin Gastroenterol
|
2009
|
0.84
|
|
55
|
Clinical correlates and diagnostic utility of osmophobia in migraine.
|
Cephalalgia
|
2012
|
0.84
|
|
56
|
Hepatocellular carcinoma with presentation of budd-Chiari syndrome.
|
J Chin Med Assoc
|
2010
|
0.83
|
|
57
|
Varied immunity generated in mice by DNA vaccines with large and small hepatitis delta antigens.
|
J Virol
|
2003
|
0.83
|
|
58
|
Interaction and replication activation of genotype I and II hepatitis delta antigens.
|
J Virol
|
2004
|
0.83
|
|
59
|
Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 Patients.
|
Medicine (Baltimore)
|
2015
|
0.83
|
|
60
|
The association of RAB18 gene polymorphism (rs3765133) with cerebellar volume in healthy adults.
|
Cerebellum
|
2014
|
0.82
|
|
61
|
Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
|
Liver Transpl
|
2008
|
0.82
|
|
62
|
Milan criteria, multi-nodularity, and microvascular invasion predict the recurrence patterns of hepatocellular carcinoma after resection.
|
J Gastrointest Surg
|
2012
|
0.82
|
|
63
|
Fever and infectious complications after percutaneous acetic acid injection therapy for hepatocellular carcinoma: incidence and risk factor analysis.
|
J Clin Gastroenterol
|
2006
|
0.82
|
|
64
|
Ethanol injection versus radiofrequency ablation for hepatocellular carcinoma: which is better?
|
Gastroenterology
|
2005
|
0.82
|
|
65
|
The lifetime cost of hepatocellular carcinoma : a claims data analysis from a medical centre in Taiwan.
|
Appl Health Econ Health Policy
|
2008
|
0.82
|
|
66
|
Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy.
|
J Gastroenterol Hepatol
|
2013
|
0.82
|
|
67
|
A comparison of clinical manifestations and prognoses between patients with hepatocellular carcinoma and Child-Pugh scores of 5 or 6.
|
Medicine (Baltimore)
|
2014
|
0.81
|
|
68
|
Pro-205 of large hepatitis delta antigen and Pro-62 of major hepatitis B surface antigen influence the assembly of different genotypes of hepatitis D virus.
|
J Gen Virol
|
2009
|
0.81
|
|
69
|
Second primary cancers in patients with hepatocellular carcinoma: a nationwide cohort study in Taiwan.
|
Liver Int
|
2013
|
0.81
|
|
70
|
Comparative analysis of noninvasive models to predict early liver fibrosis in hepatitis B e Antigen-negative Chronic Hepatitis B.
|
J Clin Gastroenterol
|
2011
|
0.81
|
|
71
|
Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
|
Oncol Rep
|
2004
|
0.81
|
|
72
|
Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.
|
Ann Hepatol
|
2013
|
0.81
|
|
73
|
The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapy.
|
J Clin Gastroenterol
|
2006
|
0.81
|
|
74
|
The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study.
|
Liver Int
|
2004
|
0.81
|
|
75
|
Analysis of humoral immunity of hepatitis D virus DNA vaccine generated in mice by using different dosage, gene gun immunization, and in vivo electroporation.
|
J Chin Med Assoc
|
2006
|
0.80
|
|
76
|
Effects of multiple virus coinfections on disease progression in HIV-positive patients.
|
Intervirology
|
2003
|
0.80
|
|
77
|
From NPC therapeutic target identification to potential treatment strategy.
|
Mol Cancer Ther
|
2010
|
0.80
|
|
78
|
Queckenstedt's test headache response is associated with increased jugular venous flow volume during migraine attack.
|
Ultrasound Med Biol
|
2011
|
0.80
|
|
79
|
Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas.
|
World J Surg
|
2004
|
0.80
|
|
80
|
Positive selection of hepatitis delta antigen in chronic hepatitis D patients.
|
J Virol
|
2007
|
0.79
|
|
81
|
Is diabetes a risk factor for hepatocellular carcinoma?
|
Gastroenterology
|
2004
|
0.79
|
|
82
|
Cholestatic jaundice as the predominant presentation in a patient with autoimmune hepatitis.
|
J Chin Med Assoc
|
2008
|
0.79
|
|
83
|
Reactivation of hepatitis B virus after transarterial chemo-embolization for hepatocellular carcinoma in one patient with negative hepatitis B surface antigen.
|
J Hepatol
|
2009
|
0.79
|
|
84
|
Generation of cytotoxicity against hepatitis delta virus genotypes and quasispecies by epitope modification.
|
J Hepatol
|
2009
|
0.78
|
|
85
|
Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence.
|
World J Surg
|
2004
|
0.78
|
|
86
|
Severe bone marrow depression induced by an anticancer herb Cantharanthus roseus.
|
J Toxicol Clin Toxicol
|
2004
|
0.77
|
|
87
|
MELD in liver transplantation: the da Vinci code for the Holy Grail?
|
J Hepatol
|
2005
|
0.77
|
|
88
|
Impact of Steatosis on Prognosis of Patients with Early-Stage Hepatocellular Carcinoma After Hepatic Resection.
|
Ann Surg Oncol
|
2014
|
0.77
|
|
89
|
Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of alpha-fetoprotein.
|
Liver Int
|
2010
|
0.77
|
|
90
|
Percutaneous injection therapy for hepatocellular carcinoma in patients with chronic renal insufficiency.
|
Eur J Gastroenterol Hepatol
|
2004
|
0.77
|
|
91
|
Hepatitis D virus isolates with low replication and epithelial-mesenchymal transition-inducing activity are associated with disease remission.
|
J Virol
|
2012
|
0.77
|
|
92
|
Comparison of clinical manifestations and epidemiology between acute hepatitis A and acute hepatitis E in Taiwan.
|
J Gastroenterol Hepatol
|
2002
|
0.77
|
|
93
|
Are alcohol, tobacco and obesity genuine risk factors for hepatocellular carcinoma?
|
J Hepatol
|
2005
|
0.76
|
|
94
|
Screening for hepatocellular carcinoma in high-risk patients: Western versus Eastern virus.
|
Hepatology
|
2003
|
0.76
|
|
95
|
Lipopolysaccharide enhanced renal vascular response to endothelin-1 through ETA overexpression in portal hypertensive rats.
|
J Gastroenterol Hepatol
|
2015
|
0.76
|
|
96
|
Different model for end-stage liver disease score block distributions may have a variable ability for outcome prediction.
|
Transplantation
|
2005
|
0.76
|
|
97
|
Queckenstedt's test affects more than jugular venous congestion in rat.
|
PLoS One
|
2013
|
0.75
|
|
98
|
Role of locoregional therapy for hepatocellular carcinoma before liver transplantation: answer or myth?
|
Liver Transpl
|
2006
|
0.75
|
|
99
|
Does hepatitis B viral load determine the outcome of patients with hepatocellular carcinoma undergoing chemotherapy?
|
Hepatology
|
2007
|
0.75
|
|
100
|
Comparison of staging systems for HCC: one more positive answer or mission impossible?
|
Hepatology
|
2005
|
0.75
|
|
101
|
Is entecavir ideal for the treatment of lamivudine-refractory chronic hepatitis B?
|
Hepatology
|
2008
|
0.75
|
|
102
|
Severe acute respiratory syndrome (SARS), a zoonotic infection with rapid spread: are we ready for the coming ones?
|
J Chin Med Assoc
|
2003
|
0.75
|
|
103
|
Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas.
|
Hepatol Int
|
2009
|
0.75
|
|
104
|
Does antibody to hepatitis B surface antigen protect renal transplant patients from hepatitis B?
|
J Gastroenterol Hepatol
|
2004
|
0.75
|
|
105
|
Which is the holy grail in liver transplantation: hyponatremia, MELD, or a combination?
|
Liver Transpl
|
2005
|
0.75
|
|
106
|
Staging for hepatocellular carcinoma: look for a perfect classification system.
|
J Hepatol
|
2004
|
0.75
|
|
107
|
Long-term outcome of hepatitis C virus superinfection in HBsAg carriers.
|
Gastroenterology
|
2004
|
0.75
|
|
108
|
Hepatitis after arterial embolization for hepatocellular carcinoma: Viral reactivation or ischemia?
|
Hepatology
|
2006
|
0.75
|
|
109
|
Risk factor analysis for cholangiocarcinoma: limitations of cross-sectional study.
|
Gastroenterology
|
2005
|
0.75
|
|
110
|
Outcomes of patients with seroclearance of HBsAg: different facets of the truth.
|
Gastroenterology
|
2003
|
0.75
|
|
111
|
Contrast medium-associated renal dysfunction in patients with cirrhosis.
|
Hepatology
|
2004
|
0.75
|
|
112
|
Comparison of self-reported cutaneous allodynia and brushing allodynia during migraine attacks.
|
Cephalalgia
|
2010
|
0.75
|
|
113
|
Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
|
Liver Transpl
|
2004
|
0.75
|
|
114
|
Chronological changes in renal vascular reactivity in portal hypertensive rats.
|
Eur J Clin Invest
|
2013
|
0.75
|
|
115
|
Successful radiofrequency ablation therapy for hepatocellular carcinoma in a male patient with early stage primary biliary cirrhosis and positive serum hepatitis B core antibody.
|
J Chin Med Assoc
|
2008
|
0.75
|
|
116
|
Genetic distinctions and clinical characteristics of type 1 autoimmune hepatitis in Taiwan.
|
Hepatogastroenterology
|
2008
|
0.75
|
|
117
|
The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
|
J Surg Oncol
|
2007
|
0.75
|
|
118
|
Zafirlukast-induced acute hepatitis.
|
Zhonghua Yi Xue Za Zhi (Taipei)
|
2002
|
0.75
|
|
119
|
Wandering abdominal pain due to a floating gallbladder.
|
Dig Liver Dis
|
2013
|
0.75
|
|
120
|
Autoimmune hepatitis combined with multiple viral infections.
|
Eur J Gastroenterol Hepatol
|
2008
|
0.75
|